Published in Lancet on September 25, 2010
Pathogenesis of implant-associated infection: the role of the host. Semin Immunopathol (2011) 1.09
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation (2012) 1.03
Age and gender disparities in the risk of carotid revascularization procedures. Neurol Sci (2013) 0.79
Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent) (2013) 0.75
Management of carotid artery stenosis: endarterectomy or stenting? Mayo Clin Proc (2010) 0.75
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial. Lancet (2010) 4.73
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78
Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol (2009) 3.88
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41
Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol (2005) 2.36
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 2.33
Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology (2003) 2.22
Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke (2009) 2.10
Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke (2010) 1.88
Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol (2010) 1.85
Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke (2005) 1.52
Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. Eur Heart J (2013) 1.47
Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis (2013) 1.43
Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol (2005) 1.43
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis (2009) 1.36
Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis (2007) 1.30
Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke (2010) 1.30
Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol (2006) 1.18
Ischemia-modified albumin in acute stroke. Cerebrovasc Dis (2006) 1.17
Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack? Stroke (2009) 1.16
Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke (2009) 1.13
Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol (2010) 1.11
Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Stroke (2012) 1.08
Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke (2011) 1.06
The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial. Trials (2013) 1.06
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol (2010) 1.05
Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke (2006) 1.02
Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J Cardiovasc Pharmacol (2011) 1.01
Basilar artery diameter and 5-year mortality in patients with stroke. Stroke (2006) 1.00
Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA study. Int J Cardiovasc Imaging (2006) 0.99
Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke (2013) 0.97
Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler Thromb Vasc Biol (2005) 0.96
Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke (2009) 0.96
Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke (2007) 0.96
Is moderate atherosclerotic stenosis in the middle cerebral artery a cause of or a coincidental finding in ischemic stroke? Cerebrovasc Dis (2009) 0.95
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke (2014) 0.95
Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing (2007) 0.94
Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke (2011) 0.92
Renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann Neurol (2005) 0.92
Correlation between the Framingham risk score and intima media thickness: the Paroi Artérielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis (2007) 0.90
Matrix metalloproteinase-3 and intracranial arterial dolichoectasia. Ann Neurol (2010) 0.90
Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study. Int J Stroke (2012) 0.90
Ethanol threshold doses for systemic complications during sclerotherapy of superficial venous malformations: a retrospective study. Neuroradiology (2010) 0.89
Country-based reference values and impact of cardiovascular risk factors on carotid intima-media thickness in a French population: the 'Paroi Artérielle et Risque Cardio-Vasculaire' (PARC) Study. Cerebrovasc Dis (2009) 0.89
Common carotid artery intima-media thickness: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study results. Cerebrovasc Dis (2010) 0.89
Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke (2004) 0.89
Protective effect of high-density lipoprotein-based therapy in a model of embolic stroke. Stroke (2010) 0.88
Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation. Stroke (2011) 0.87
Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovasc Dis (2011) 0.87
The renin-angiotensin-aldosterone system in cerebral small vessel disease. J Neurol (2008) 0.87
Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm. Arterioscler Thromb Vasc Biol (2008) 0.86
Predictive values of lacunar transient ischemic attacks. Stroke (2004) 0.86
Fatal peritoneal bleeding following embolization of a carotid-cavernous fistula in Ehlers-Danlos syndrome type IV. Cardiovasc Intervent Radiol (2006) 0.86
High blood pressure in early acute stroke: a sign of a poor outcome? J Hypertens (2006) 0.85
Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal stroke. Stroke (2007) 0.85
Association of small-vessel disease with dilatative arteriopathy of the brain: neuropathologic evidence. Stroke (2007) 0.85
Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology. J Vasc Interv Neurol (2014) 0.84
Dramatic recovery in acute ischemic stroke is associated with arterial recanalization grade and speed. Stroke (2012) 0.84
Blood lipids in brain infarction subtypes. Cerebrovasc Dis (2006) 0.84
Spectrum of transient visual symptoms in a transient ischemic attack cohort. Stroke (2013) 0.84
Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke (2011) 0.83
Coronary artery disease and risk of major vascular events after cerebral infarction. Stroke (2013) 0.83
Blood-brain barrier disruption is associated with increased mortality after endovascular therapy. Neurology (2013) 0.83
Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease. Cerebrovasc Dis (2013) 0.83
Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 0.83
Outcomes after stroke thrombolysis according to prior antiplatelet use. Int J Stroke (2014) 0.82
Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry. Int J Stroke (2012) 0.82
High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke. Stroke (2013) 0.81
Impact of living and socioeconomic characteristics on cardiovascular risk in ischemic stroke patients. Int J Stroke (2014) 0.81
High-density lipoproteins limit neutrophil-induced damage to the blood-brain barrier in vitro. J Cereb Blood Flow Metab (2013) 0.80
Overlap of diseases underlying ischemic stroke: the ASCOD phenotyping. Stroke (2013) 0.80
Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke (2013) 0.80
Stroke and vascular mortality trends in France: 1979-2001. Neuroepidemiology (2007) 0.80
Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion therapy. Stroke (2013) 0.80
A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. Circulation (2012) 0.79
Rupture of nonstenotic carotid plaque as a cause of ischemic stroke evidenced by multimodality imaging. Circulation (2014) 0.79
Thrombomodulin gene polymorphisms in brain infarction and mortality after stroke. J Neurol (2008) 0.78
Carotid endarterectomy in the acute phase of crescendo cerebral transient ischemic attacks is safe and effective. J Vasc Surg (2010) 0.78